Arrowstreet Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-21,445
Closed -$2.21M 1478
2023
Q2
$2.21M Buy
21,445
+1,723
+9% +$177K ﹤0.01% 799
2023
Q1
$2.15M Sell
19,722
-21,558
-52% -$2.35M ﹤0.01% 888
2022
Q4
$4.7M Buy
+41,280
New +$4.7M 0.01% 693
2022
Q3
Sell
-911,752
Closed -$72.7M 1530
2022
Q2
$72.7M Buy
911,752
+97,141
+12% +$7.75M 0.1% 177
2022
Q1
$85.7M Buy
814,611
+476,600
+141% +$50.1M 0.11% 186
2021
Q4
$36.4M Buy
+338,011
New +$36.4M 0.04% 344
2021
Q3
Sell
-48,011
Closed -$4.5M 2030
2021
Q2
$4.5M Buy
+48,011
New +$4.5M 0.01% 1105
2020
Q3
Sell
-8,700
Closed -$484K 2656
2020
Q2
$484K Buy
+8,700
New +$484K ﹤0.01% 1975
2019
Q3
Sell
-395,041
Closed -$9.51M 1830
2019
Q2
$9.51M Sell
395,041
-18,175
-4% -$437K 0.02% 496
2019
Q1
$10.9M Buy
+413,216
New +$10.9M 0.03% 538
2015
Q1
Sell
-38,506
Closed -$496K 1318
2014
Q4
$496K Buy
+38,506
New +$496K ﹤0.01% 1043